StonvexLoading…
StonvexStonvexStonvexCore line items from ILMN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-29 | Annual 2025 2025-12-28 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 |
|---|---|---|---|---|
Revenue | $1.09B | $4.34B | $3.18B | $2.10B |
Operating Income | $209.00M | $807.00M | $606.00M | $378.00M |
Net Income | $134.00M | $334.00M | $150.00M | $235.00M |
EPS (Diluted) | $0.87 | $5.45 | $3.29 | $2.31 |
Total Assets | $6.56B | $6.64B | $6.18B | $6.09B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.09B | $1.42B | $1.05B | $934.00M |
Free Cash Flow OCF − CapEx | $251.00M | $931.00M | $665.00M | $412.00M |
Shares Outstanding | 154.00M | 153.00M | 157.00M | 158.00M |